However layoffs could be inevitable in such a giant merger, analysts say, and Pfizer has a monitor record of eliminating tens of thousands of jobs because of megadeals.
What's conserving progress from being made, Sharfstein and Kapoor say, is an ongoing dispute over whether the products work.